Cetirizine is a globally trusted H1-receptor antagonist, recommended by evidence-based guidelines for the treatment of PAR. Backed by significant research, this antihistamine offers superior symptom relief and improved quality of life for patients.1,2,3
• Tolerability: Cetirizine was well tolerated with minimal side effects.
Cetirizine provides powerful relief, helping patients manage nasal congestion, sleep disruptions, and emotional stress linked to PAR.
Reference:
1. Bousquet J, Duchateau J, Pignat JC, et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol. 1996;98(2):309-16.
2. Agrawal VK, Patel S, Petare AU, et al. Improving the quality of life in the management of allergic rhinitis: New perspective on cetirizine. J Assoc Physicians India. 2022;70(6):78-82.
3. Zhang L, Cheng L, Hong J. The clinical use of cetirizine in the treatment of allergic rhinitis. Pharmacology. 2013;92 (1-2):14-25.
4. Skoner DP, LaForce CF, Nathan RA, et al. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis. Allergy Asthma Proc. 2014;35(4):338-45.
For the use of a Registered Medical Practitioner, Hospital or a Laboratory only. GGI-CO-A1-AQS-300037324-DVC-J24-0933
All content including: text, images, audio, or other formats were created for medical educational purposes only. This communication is restricted for the use of HCPs and must not be shared in public domain. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s. Images appearing herein are for illustration purposes only.
